Skip to content

PAS GRAS - Risk stratification for the development of obesity and associated comorbidities from childhood and adolescence due to socioeconomic, lifestyle and cardiometabolic factors

PAS GRAS - Risk stratification for the development of obesity and associated comorbidities from childhood and adolescence due to socioeconomic, lifestyle and cardiometabolic factors - PAS GRAS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036158
Enrollment
500
Registered
2026-06-18
Start date
2024-07-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66.09 E11.90 E88.9 R73.0

Interventions

Group 1: Children and adolescents with overweight or obesity Nutritional intervention: Mediterranean diet, counseling, and medical history assessment at T0, T1 (after 3 months), and T2 (after 6 months

Sponsors

Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: Arm 1: - BMI > 90. percentile (Kromeyer-Hausschild) - Written informed consent of parents or guardians or of participants aged 16 years and older Arm 2: - BMI > 90. percentile (Kromeyer-Hausschild) - Participation in the KLAKS physical education program - Written informed consent of parents or guardians or of participants aged 16 years and older Arm 3: - BMI > 90. percentile (Kromeyer-Hausschild) - Diagnosed type 2 diabetes (HbA1c of 6.5–11.1%, fasting glucose = 7.0 mmol/l, or 120-minute OGTT glucose level = 7.8 mmol/l) - Written informed consent of parents or guardians or of participants aged 16 years and older Arm 4: - BMI < 90. percentile (Kromeyer-Hausschild) - Written informed consent of parents or guardians or of participants aged 16 years and older

Exclusion criteria

Exclusion criteria: Arm 1: - Syndromal obesity - Pregnancy - Chronic underlying disease that prevents participation in the study Arm 2: - Syndromal obesity - Pregnancy - Chronic underlying disease that prevents participation in the study Arm 3: - Syndromal obesity -MODY-Diabetes - Pregnancy - Chronic underlying disease that prevents participation in the study Arm 4: - Diagnosed metabolic disorder - Pregnancy - Chronic underlying disease that prevents participation in the study

Design outcomes

Primary

MeasureTime frame
- Change in BHI as a marker for mitochondrial function as a function of metabolic status and nutritional intervention (at T1 after 3 months and T2 after 6 months, measured using extracellular flux analysis) - Change in anthropometric parameters (BMI-SDS, WHtR, body fat percentage) due to the influence of a Mediterranean Diet or increased physical activity (at T1 and T2)

Secondary

MeasureTime frame
- Changes in other cardiometabolic risk markers of the Metabolic Syndrom (lipid profile, uric acid, transaminases, glucose homeostasis) - Changes in metabolic status (NBZ, insulin, HbA1c, Advanced Glycation Endproducts) - Identification of new risk parameters

Countries

Germany

Contacts

Public ContactSusann Weihrauch-Blüher

Universitätsmedizin Halle (Saale)

susann.weihrauch-blueher@uk-halle.de+493455571450

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 29, 2026